Ocular Therapeutix: 4Q Earnings Snapshot

March 12, 2020 GMT

BEDFORD, Mass. (AP) _ Ocular Therapeutix Inc. (OCUL) on Thursday reported a loss of $26 million in its fourth quarter.

On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 53 cents. Losses, adjusted for non-recurring costs, came to 47 cents per share.

The biotechnology company posted revenue of $2.3 million in the period.

For the year, the company reported that its loss widened to $86.4 million, or $1.91 per share. Revenue was reported as $4.2 million.

In the final minutes of trading on Thursday, the company’s shares hit $4.29. A year ago, they were trading at $4.36.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL